Literature DB >> 7685422

Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup.

J I Epstein1, M J Carmichael, G Pizov, P C Walsh.   

Abstract

We studied 196 radical prostatectomy cases performed for clinical stage B prostate cancer with capsular penetration; in all cases seminal vesicles and lymph nodes were free of tumor. The mean followup in patients who showed no evidence of progression was 5 years. Focal capsular penetration was seen in 93 cases. There was no difference in progression in this group, irrespective of whether margins were negative or positive. High grade tumors (Gleason score 7 or more) had a significantly higher risk of progression compared to lower grade tumors (p = 0.0002). Established capsular penetration was seen in 103 tumors. Cancers with established capsular penetration had a higher risk of progression than those with focal capsular penetration. Established capsular penetration tumors were stratified into 3 groups with increasing risks of progression: 1) margins were negative and grade was low, 2) margins were positive or grade was high yet both adverse features were not present or 3) margins were positive and grade was high. The differences in progression among these 3 groups were statistically significant. Because of the negligible influence of positive margins in patients with focal capsular penetration the status of capsular margins should not influence the decision on whether to administer immediate postoperative adjuvant therapy. To evaluate the efficacy of adjuvant therapy following radical prostatectomy, tumors with capsular penetration should be stratified into groups having similar risks of progression according to the extent of capsular penetration, surgical margins of resection and grade.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685422     DOI: 10.1016/s0022-5347(17)35415-0

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  40 in total

1.  Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI.

Authors:  B Nicolas Bloch; Elizabeth M Genega; Daniel N Costa; Ivan Pedrosa; Martin P Smith; Herbert Y Kressel; Long Ngo; Martin G Sanda; William C Dewolf; Neil M Rofsky
Journal:  Eur Radiol       Date:  2012-06-03       Impact factor: 5.315

Review 2.  Three dimensional ultrasound and prostate cancer.

Authors:  S S Mehta; A R Azzouzi; F C Hamdy
Journal:  World J Urol       Date:  2004-11-12       Impact factor: 4.226

Review 3.  Primary staging of prostate cancer.

Authors:  G J Jager; J O Barentz; E T Ruijter; J J de la Rosette; G O Oosterhof
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

Review 4.  Localised carcinoma of the prostate: a paradigm of uncertainty.

Authors:  S S Sandhu; A V Kaisary
Journal:  Postgrad Med J       Date:  1997-11       Impact factor: 2.401

5.  Impact of the extent of extraprostatic extension defined by Epstein's method in patients with negative surgical margins and negative lymph node invasion.

Authors:  T Maubon; N Branger; C Bastide; G Lonjon; K-A Harvey-Bryan; P Validire; S Giusiano; D Rossi; X Cathelineau; F Rozet
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-07-12       Impact factor: 5.554

6.  A Grading System for Extraprostatic Extension of Prostate Cancer That We Can All Agree Upon?

Authors:  Peter L Choyke
Journal:  Radiol Imaging Cancer       Date:  2020-01-17

7.  Can 3T multiparametric magnetic resonance imaging accurately detect prostate cancer extracapsular extension?

Authors:  Yannick Cerantola; Massimo Valerio; Aida Kawkabani Marchini; Jean-Yves Meuwly; Patrice Jichlinski
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

8.  The role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: the Beth Israel Deaconess Medical Center (BIDMC) approach.

Authors:  B Nicolas Bloch; Robert E Lenkinski; Neil M Rofsky
Journal:  Cancer Biomark       Date:  2008       Impact factor: 4.388

9.  [(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy.

Authors:  Giampiero Giovacchini; Maria Picchio; Elisa Coradeschi; Vincenzo Scattoni; Valentino Bettinardi; Cesare Cozzarini; Massimo Freschi; Ferruccio Fazio; Cristina Messa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-16       Impact factor: 9.236

Review 10.  Pathologic basis of focal therapy for early-stage prostate cancer.

Authors:  Vladimir Mouraviev; Janice M Mayes; Thomas J Polascik
Journal:  Nat Rev Urol       Date:  2009-04       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.